AR086876A1 - Derivados heterociclicos de sulfonamida - Google Patents
Derivados heterociclicos de sulfonamidaInfo
- Publication number
- AR086876A1 AR086876A1 ARP120102040A ARP120102040A AR086876A1 AR 086876 A1 AR086876 A1 AR 086876A1 AR P120102040 A ARP120102040 A AR P120102040A AR P120102040 A ARP120102040 A AR P120102040A AR 086876 A1 AR086876 A1 AR 086876A1
- Authority
- AR
- Argentina
- Prior art keywords
- sulfonamide
- heterociclic
- derivatives
- compounds
- heterociclic derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Compuestos; composición farmacéutica y proceso de preparación de compuesto de fórmula (1) y (2), y sales farmacéuticamente aceptables de los mismos. Los compuestos se han demostrado como inhibidores de MEK y por lo tanto pueden ser útiles en el tratamiento de enfermedades hiperproliferativas como el cáncer y la inflamación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1634DE2011 | 2011-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR086876A1 true AR086876A1 (es) | 2014-01-29 |
Family
ID=47293670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120102040A AR086876A1 (es) | 2011-06-09 | 2012-06-08 | Derivados heterociclicos de sulfonamida |
Country Status (5)
Country | Link |
---|---|
US (1) | US8470878B2 (es) |
CN (1) | CN103748085A (es) |
AR (1) | AR086876A1 (es) |
TW (1) | TW201302721A (es) |
UY (1) | UY34121A (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105384754B (zh) * | 2014-09-02 | 2018-04-20 | 上海科州药物研发有限公司 | 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途 |
WO2017033113A1 (en) | 2015-08-21 | 2017-03-02 | Acerta Pharma B.V. | Therapeutic combinations of a mek inhibitor and a btk inhibitor |
US11806321B2 (en) * | 2022-03-17 | 2023-11-07 | Springworks Therapeutics, Inc. | Non-linear dosing of mirdametinib |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002051821A1 (en) | 2000-12-22 | 2002-07-04 | Astrazeneca Ab | Therapeutic compounds |
EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
WO2003045930A1 (en) | 2001-11-28 | 2003-06-05 | Astrazeneca Ab | Therapeutic compounds |
PL1637527T3 (pl) | 2003-06-26 | 2013-09-30 | Takeda Pharmaceuticals Co | Modulator receptora kanabinoidowego |
GB0420719D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
SI1986633T1 (sl) | 2006-02-10 | 2015-03-31 | Summit Corporation Plc | Zdravljenje Duchennove mišične distrofije |
AU2008206045A1 (en) * | 2007-01-19 | 2008-07-24 | Ardea Biosciences, Inc. | Inhibitors of MEK |
JP5479337B2 (ja) | 2007-07-30 | 2014-04-23 | アルディア バイオサイエンス,インク. | Mek阻害剤およびrafキナーゼ阻害剤の組み合わせ、ならびにその使用 |
JP2010535708A (ja) | 2007-08-03 | 2010-11-25 | ビオマリン アイジーエー リミテッド | デュシェンヌ型筋ジストロフィーの治療のための薬物併用 |
US20110098288A1 (en) | 2008-03-11 | 2011-04-28 | Jeremy Major | Sulfonamides as zap-70 inhibitors |
CN102134218A (zh) | 2009-06-15 | 2011-07-27 | 凯美隆(北京)药业技术有限公司 | 6-芳氨基吡啶酮磺酰胺和6-芳氨基吡嗪酮磺酰胺mek抑制剂 |
EP2509964B1 (en) * | 2009-12-08 | 2014-04-30 | Novartis AG | Heterocyclic sulfonamide derivatives |
-
2012
- 2012-06-06 CN CN201280037903.6A patent/CN103748085A/zh active Pending
- 2012-06-07 US US13/491,205 patent/US8470878B2/en not_active Expired - Fee Related
- 2012-06-08 AR ARP120102040A patent/AR086876A1/es not_active Application Discontinuation
- 2012-06-08 UY UY0001034121A patent/UY34121A/es not_active Application Discontinuation
- 2012-06-08 TW TW101120800A patent/TW201302721A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US8470878B2 (en) | 2013-06-25 |
US20120316149A1 (en) | 2012-12-13 |
TW201302721A (zh) | 2013-01-16 |
UY34121A (es) | 2013-01-31 |
CN103748085A (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
CO2017002998A2 (es) | Derivados de tetrahidronaftaleno que inhiben la proteína mcl-1 | |
CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
DOP2014000152A (es) | Inhibidores de bromodominios | |
EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
UY33183A (es) | Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento | |
MX2014012695A (es) | Derivados de isoindolona. | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
CR11641A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
EA201591195A1 (ru) | Новые хинолоновые производные | |
EA201490471A1 (ru) | Пиридазиноновые соединения и их применение в качестве ингибиторов daao | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
UA113215C2 (xx) | Похідні проліків (e)-n-метил-n-((3-метилбензофуран-2-іл)метил)-3-(7-оксо-5,6,7,8-тетрагідро-1,8-нафтиридин-3-іл)акриламіду | |
MX2015016425A (es) | Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades. | |
EA201600434A1 (ru) | Применение производных бензимидазолпролина | |
CY1120133T1 (el) | Πυριδαζινονες ως αναστολεις ενζυμου daao | |
UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
UY32856A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
UY32694A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
ECSP12011984A (es) | Derivados de sulfonamida heterocíclicos | |
EA201490573A1 (ru) | Соединение бензотиазолона | |
EA201391820A1 (ru) | Гетероциклические сульфонамидные производные | |
AR086876A1 (es) | Derivados heterociclicos de sulfonamida | |
UY33806A (es) | ?compuestos novedosos de imidazoquinolina, composiciones que los contienen y su uso en el tratamiento de enfermedades mediadas por tlr7? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |